Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NuVasive Inc (NASDAQ:NUVA)

Delayed Data
As of Nov 25
 +0.33 / +0.63%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

NuVasive, Inc. is a medical device company, which is focused on the design, development, and market of surgical products to treat the spine. Its products include a minimally disruptive surgical platform called Maximum Access Surgery, in addition to biologics, cervical and motion preservation products, and Intra-Operative Monitoring services. The surgical products for the spine include devices for the thoracolumbar spine, the cervical spine, and a set of motion. The product offerings that are still under development are primarily used to gain access to the spine to perform restorative and fusion procedures in a minimally disruptive fashion. Its biologic product line offerings include allograft, FormaGraft, a collagen synthetic product, Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells and AttraX, a synthetic bone graft material, all used to aid the spinal fusion process. The company was founded on July 21, 1997 and is headquartered in San Diego, CA.

Contact Information

NuVasive, Inc.
7475 Lusk Boulevard
San Diego California 92121
P:(858) 909-1800
Investor Relations:
(858) 909-1812



Mutual fund holders55.40%
Other institutional48.66%
Individual stakeholders15.13%

Top Executives

Gregory T. LucierChairman & Chief Executive Officer
Patrick MilesPresident & Chief Operating Officer
Quentin BlackfordChief Financial Officer & Executive Vice President
G. Bryan CornwallSenior VP-Clinical Operations & Research
Johnson LaiChief Information Officer